Aerosol Disease
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Emission Patterns of Respiratory Syncytial Virus
Biocontainment Device for Aerosol Generating Procedures
A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients
Hydrogen Peroxide Fumigation in Dental Office Environment
Quantitative Evaluation of Aerosols Produced in the Dental Office
Aerosol Particle From EGD in Patients With and Without Head Box in COVID-19 Era
Dental Isolation Methods in Pediatric Patients
OSE as a Pre-procedural Mouth Rinse: A Clinical and Microbiological Study.